CoChat

Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages

Open access
Tate, Mitchel, Robinson, Emma, Green, Brian D., McDermott, Barbara J., Grieve, David J. · 2016 · Basic Research in Cardiology

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

In addition to its' established metabolic and cardioprotective effects, glucagon-like peptide-1 (GLP-1) reduces post-infarction heart failure via preferential actions on the extracellular matrix (ECM). Here, we investigated whether the GLP-1 mimetic, exendin-4, modulates cardiac remodelling in experimental diabetes by specifically targeting inflammatory/ECM pathways, which are characteristically dysregulated in this setting. Adult mice were subjected to streptozotocin (STZ) diabetes and infused with exendin-4/insulin/saline from 0 to 4 or 4-12 weeks. Exendin-4 and insulin improved metabolic parameters in diabetic mice after 12 weeks, but only exendin-4 reduced cardiac diastolic dysfunction and interstitial fibrosis in parallel with altered ECM gene expression. Whilst myocardial inflammation was not evident at 12 weeks, CD11b-F4/80(++) macrophage infiltration at 4 weeks was increased and reduced by exendin-4, together with an improved cytokine profile. Notably, media collected from high glucose-treated macrophages induced cardiac fibroblast differentiation, which was prevented by exendin-4, whilst several cytokines/chemokines were differentially expressed/secreted by exendin-4-treated macrophages, some of which were modulated in STZ exendin-4-treated hearts. Our findings suggest that exendin-4 preferentially protects against ECM remodelling and diastolic dysfunction in experimental diabetes via glucose-dependent modulation of paracrine communication between infiltrating macrophages and resident fibroblasts, thereby indicating that cell-specific targeting of GLP-1 signalling may be a viable therapeutic strategy in this setting.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00395-015-0518-1

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Effect of exendin-4 and insulin on metabolic characteristics after 12 weeks STZ diabetes. Terminal blood assessment of a plasma glucose (n = 5–18), b HbA1c (n = 6–13), c triglyceride (n = 6–14) and d cholesterol (n = 6–11). e Representative images of pancreatic islets stained with insulin and glucagon, with quantification of f β-cell area, g number of islets and h islet area (all n = 6–13). White columns control; black columns exendin-4; grey columns insulin; mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001, versus corresponding vehicle; † P < 0.05; †† P < 0.01; ††† P < 0.001 versus STZ control
Fig. 1 Effect of exendin-4 and insulin on metabolic characteristics after 12 weeks STZ diabetes. Terminal blood assessment of a plasma glucose (n = 5–18), b HbA1c (n = 6–13), c triglyceride (n = 6–14) and d cholesterol (n = 6–11). e Representative images of pancreatic islets stained with insulin and glucagon, with quantification of f β-cell area, g number of islets and h islet area (all n = 6–13). White columns control; black columns exendin-4; grey columns insulin; mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001, versus corresponding vehicle; † P < 0.05; †† P < 0.01; ††† P < 0.001 versus STZ controlCC BY · PubMed Central
Fig. 2 Effect of exendin-4 on ECM remodelling and myocardial inflammation after 12 weeks STZ diabetes. a Representative LV sections stained with picrosirius red to assess interstitial fibrosis and quantification data (n = 6–13). b–e, h, i mRNA expression of ECM genes/cytokines in LV tissue (n = 5–8). f–g Quantification of LV sections probed for CD45 and F4/80 to assess leukocyte and macrophage infiltration, respectively (n = 4–8). White columns control; black columns exendin-4; grey columns insulin; mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001 versus corresponding vehicle; † P < 0.05; †† P < 0.01 versus corresponding control
Fig. 2 Effect of exendin-4 on ECM remodelling and myocardial inflammation after 12 weeks STZ diabetes. a Representative LV sections stained with picrosirius red to assess interstitial fibrosis and quantification data (n = 6–13). b–e, h, i mRNA expression of ECM genes/cytokines in LV tissue (n = 5–8). f–g Quantification of LV sections probed for CD45 and F4/80 to assess leukocyte and macrophage infiltration, respectively (n = 4–8). White columns control; black columns exendin-4; grey columns insulin; mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001 versus corresponding vehicle; † P < 0.05; †† P < 0.01 versus corresponding controlCC BY · PubMed Central
Fig. 3 Effect of exendin-4 on myocardial inflammation after 4 weeks STZ diabetes. Representative LV sections probed for a CD45 and b F4/80, to assess leukocyte and macrophage infiltration, respectively, together with mean quantification data analysing ten high power fields per section (n = 5–6). c–e cytokine mRNA expression in LV tissue (n = 5–7). White columns control; black columns exendin-4; mean ± SEM. *P < 0.05; ***P < 0.001 versus corresponding vehicle; † P < 0.05 versus STZ control
Fig. 3 Effect of exendin-4 on myocardial inflammation after 4 weeks STZ diabetes. Representative LV sections probed for a CD45 and b F4/80, to assess leukocyte and macrophage infiltration, respectively, together with mean quantification data analysing ten high power fields per section (n = 5–6). c–e cytokine mRNA expression in LV tissue (n = 5–7). White columns control; black columns exendin-4; mean ± SEM. *P < 0.05; ***P < 0.001 versus corresponding vehicle; † P < 0.05 versus STZ controlCC BY · PubMed Central
Fig. 4 Effect of exendin-4 on paracrine communication between bone marrow-derived macrophages and cardiac fibroblasts. a–d mRNA expression of myofibroblast differentiation markers in basal and TGF-β-stimulated cardiac fibroblasts incubated in conditioned media from BMDM treated with normal/high glucose with/without exendin-4 for 24 h (n = 6). e Cytokine/chemokine array blots from BMDM-conditioned media with quantification of protein expression (pooled from four preparations). White columns normal glucose control; black columns normal glucose exendin-4; light grey columns high glucose control; dark grey columns high glucose exendin-4; mean ± SEM. **P < 0.01; ***P < 0.001 versus corresponding vehicle; †† P < 0.01; ††† P < 0.001 versus corresponding glucose control; # P < 0.05; ### P < 0.001 versus corresponding normal glucose
Fig. 4 Effect of exendin-4 on paracrine communication between bone marrow-derived macrophages and cardiac fibroblasts. a–d mRNA expression of myofibroblast differentiation markers in basal and TGF-β-stimulated cardiac fibroblasts incubated in conditioned media from BMDM treated with normal/high glucose with/without exendin-4 for 24 h (n = 6). e Cytokine/chemokine array blots from BMDM-conditioned media with quantification of protein expression (pooled from four preparations). White columns normal glucose control; black columns normal glucose exendin-4; light grey columns high glucose control; dark grey columns high glucose exendin-4; mean ± SEM. **P < 0.01; ***P < 0.001 versus corresponding vehicle; †† P < 0.01; ††† P < 0.001 versus corresponding glucose control; # P < 0.05; ### P < 0.001 versus corresponding normal glucoseCC BY · PubMed Central
Fig. 5 Effect of exendin-4 on mRNA expression in bone marrow derived macrophages incubated in normal and high glucose for 72 h. Real-time RT-PCR analysis of transcript levels of a IL-1β, b IL-10, c CD11b, d CCL2, e bFGF, and f MMP-9 were analysed (n = 4). White columns control; black columns exendin-4; mean ± SEM. **P < 0.01; ***P < 0.001 versus corresponding vehicle, † P < 0.05; †† P < 0.01, versus normal glucose exendin-4
Fig. 5 Effect of exendin-4 on mRNA expression in bone marrow derived macrophages incubated in normal and high glucose for 72 h. Real-time RT-PCR analysis of transcript levels of a IL-1β, b IL-10, c CD11b, d CCL2, e bFGF, and f MMP-9 were analysed (n = 4). White columns control; black columns exendin-4; mean ± SEM. **P < 0.01; ***P < 0.001 versus corresponding vehicle, † P < 0.05; †† P < 0.01, versus normal glucose exendin-4CC BY · PubMed Central
Fig. 6 Effect of exendin-4 on cardiac candidate cytokine and chemokine expression after 4 weeks STZ diabetes. a–f Cytokine and chemokine mRNA expression in LV tissue (n = 5–7). White columns control; black columns exendin-4; mean ± SEM. *P < 0.05 versus vehicle control; † P < 0.05 versus STZ control
Fig. 6 Effect of exendin-4 on cardiac candidate cytokine and chemokine expression after 4 weeks STZ diabetes. a–f Cytokine and chemokine mRNA expression in LV tissue (n = 5–7). White columns control; black columns exendin-4; mean ± SEM. *P < 0.05 versus vehicle control; † P < 0.05 versus STZ controlCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 96

Metadata

Authors
Tate, M., Robinson, E., Green, B. D., McDermott, B. J., & Grieve, D. J.
Affiliations
Queen's University Belfast (GB)
Corresponding author
Grieve, David J.
Venue
Basic Research in Cardiology
Published
2015-11-23
Volume
111
Issue
1
Pages
1-1
ISSN
  • 0003-9217 (ISSN-L)
  • 0300-8428
  • 1435-1803
OpenAlex
W2239026788
Cited by
96
References
52
Citations by year
2026: 2 · 2025: 6 · 2024: 9 · 2023: 3 · 2022: 6 · 2021: 11 · 2020: 15 · 2019: 5 · 2018: 13 · 2017: 15 · 2016: 11
FWCI
9.44
Type
journal article
Language
en
Open access
Locations
  • Basic Research in Cardiology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
Funders
British Heart Foundation (PG/09/102, FS/11/36/28872)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
exendin-4, glucagon-like peptide-1, cardiac remodeling, streptozotocin-induced diabetes, macrophage infiltration, extracellular matrix remodeling, myocardial fibrosis, diastolic dysfunction, cardiac fibroblast differentiation, paracrine signaling, insulin, heart failure
MeSH terms
Exenatide, Animals, Diabetes Mellitus, Experimental, Extracellular Matrix, Fibroblasts, Flow Cytometry, Heart, Hypoglycemic Agents, Immunohistochemistry, Macrophages, Male, Mice, Inbred C57BL, Peptides, Venoms, Polymerase Chain Reaction, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages. https://app.cochat.ai/papers/10.1007/s00395-015-0518-1
The paper
Tate, M., Robinson, E., Green, B. D., McDermott, B. J., & Grieve, D. J. (2016). Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages. Basic Research in Cardiology. https://doi.org/10.1007/s00395-015-0518-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.